Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff M Slezak

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Lancet. Respiratory Medicine|April 25, 2022
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Annals of Vascular Surgery|April 27, 2012
The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repairJose M Sarmiento, Paul J Wisniewski, Natalie T Do, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
JAMA Network Open|August 3, 2022
Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 YearsSara Y Tartof, Timothy B Frankland, Jeff M Slezak, et al.
The Lancet. Respiratory Medicine|October 10, 2022
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
BJU International|April 21, 2017
Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse populationGary W Chien, Jeff M Slezak, Teresa N Harrison, et al.
American Journal of Public Health|October 16, 2015
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013Rulin C Hechter, Chun R Chao, Margo A Sidell, et al.
JAMA Internal Medicine|June 24, 2024
Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19Sara Y Tartof, Jeff M Slezak, Timothy B Frankland, et al.
Scientific Reports|March 30, 2024
Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health systemDeborah E Malden, John M McLaughlin, Vennis Hong, et al.
Vaccine|May 15, 2012
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young womenSteven J Jacobsen, Lina S Sy, Bradley K Ackerson, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Lancet. Respiratory Medicine|April 25, 2022
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Annals of Vascular Surgery|April 27, 2012
The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repairJose M Sarmiento, Paul J Wisniewski, Natalie T Do, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
JAMA Network Open|August 3, 2022
Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 YearsSara Y Tartof, Timothy B Frankland, Jeff M Slezak, et al.
The Lancet. Respiratory Medicine|October 10, 2022
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
BJU International|April 21, 2017
Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse populationGary W Chien, Jeff M Slezak, Teresa N Harrison, et al.
American Journal of Public Health|October 16, 2015
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013Rulin C Hechter, Chun R Chao, Margo A Sidell, et al.
JAMA Internal Medicine|June 24, 2024
Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19Sara Y Tartof, Jeff M Slezak, Timothy B Frankland, et al.
Scientific Reports|March 30, 2024
Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health systemDeborah E Malden, John M McLaughlin, Vennis Hong, et al.
Vaccine|May 15, 2012
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young womenSteven J Jacobsen, Lina S Sy, Bradley K Ackerson, et al.
Pageof 6